ACP domain | OR | 95% CI |
---|---|---|
Baseline completion of ACP discussion with loved ones (all participants) | ||
Social support (ENRICHD scale) | 1.10 | 1.04 to 1.65 |
Education level (completed secondary school) | 1.84 | 0.89 to 3.82 |
Baseline completion of ACP discussion with doctors (all participants) | ||
Health related quality of life (EQ-5D-5L index score) | 0.14 | 0.03 to 0.64 |
COPD diagnosis | 1.94 | 0.86 to 4.36 |
Gender (female vs male) | 1.83 | 0.87 to 3.85 |
Postintervention informal ACP uptake (of those assigned to ACP intervention) | ||
(Baseline) social support (ENRICHD scale) | 0.85 | 0.75 to 0.96 |
Participation in ≥2 facilitated ACP discussions (vs none) | 5.18 | 1.07 to 25.1 |
Family/carer involved in a facilitated ACP discussion (vs not) | 4.34 | 1.21 to 15.5 |
(Baseline) MRC shortness of breath grade 4–5 (vs not) | 4.25 | 1.42 to 12.7 |
Preferential assignment to ACP intervention (vs random) | 3.32 | 1.18 to 9.33 |
Postintervention formal ACP uptake (of those assigned to ACP intervention) | ||
Participation in ≥2 facilitated ACP discussions (vs none) | 7.02 | 1.73 to 35.1 |
Participation in one facilitated ACP discussion (vs none) | 4.53 | 1.12 to 18.3 |
Preferential assignment to ACP intervention (vs random) | 5.81 | 2.29 to 14.7 |
(Baseline) eligibility for LTOT (vs ineligible) | 3.29 | 1.22 to 8.88 |
Follow-up completion rates are calculated by supplementing self-report survey measures with follow-up medical notes audit, to include ACP undertaken by patients who were deceased or otherwise lost to survey follow-up.
ACP, advance care planning; COPD, chronic obstructive pulmonary disease; EQ-5D-5L, EuroQol 5 Dimensions 5 Level Survey; MRC, Medical Research Council.